https://www.selleckchem.com/pr....oducts/Masitinib-(AB
Gastrointestinal angiodysplasia (GIA) is the most common cause of occult gastrointestinal bleeding (GI requiring often hospitalization and transfusions, especially in patients with hemorrhagic disorders. Thalidomide, impairing neo-angiogenesis, has been successfully used in the management of bleeding in patients with GIA and in particular in patients with inherited bleeding disorders. Only one case of short-term treatment with thalidomide in a patient with Glanzmann thrombasthenia (GT) and recurrent GIB due to GIA has been
Like
Comment
Share
